Clinical Trial Update: Observational Study on the Use of Akynzeo® in Patients Receiving HEC

View source ↗

Summary

An observational study update on the use of Akynzeo in patients receiving high-emetogenic chemotherapy (HEC) for chemotherapy-induced nausea and vomiting, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Akynzeo (netupitant/palonosetron)

Snippet

Sponsor: Purdue Pharma, Canada | Conditions: Chemotherapy-Induced Nausea and Vomiting | Status: COMPLETED | Results posted: 2023-08-18